Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01822756
Title An Open-Label Study of Ruxolitinib Given With Chemotherapy in Patients With Advanced Solid Tumors
Recruitment Terminated
Gender both
Phase Phase I
Variant Requirements No
Sponsors Incyte Corporation
Indications
Therapies
Age Groups: adult
Covered Countries USA

Facility Status City State Zip Country Details
Birmingham Alabama United States Details
Gainesville Florida United States Details
Sarasota Florida United States Details
Durham North Carolina United States Details
Nashville Tennessee United States Details
*Shaded cells indicate that there was no data available from clincialtrials.gov for the field